TrialPanorama/TrialPanorama-database huggingface dataset:
Study 35398843 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 34301736 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 33142493 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33142493 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32873147 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33497715 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 33497715 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study 36079749 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36079749 — Surrogate Endpoint (SUR): Blood pressure
Study 34101010 — Safety Biomarker (SAF): Lactotransferrin
Genes: LTF; GIG12; LF
Study 34537744 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35996694 — Predictive Biomarker (PRD): DOCK3 mRNA
Genes: DOCK3; KIAA0299; MOCA
Study 35996694 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 35996694 — Predictive Biomarker (PRD): TSPAN31 mRNA
Genes: TSPAN31; SAS
Study 36017021 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36017021 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32191598 — Surrogate Endpoint (SUR): Serum testosterone
Study 35606235 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35606235 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 32016310 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 32016310 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 32616067 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 35287641 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35511431 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 32015556 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33657181 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 33657181 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33221262 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 36469000 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 34058654 — Surrogate Endpoint (SUR): Blood pressure
Study 33990490 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33051342 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33051342 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32853647 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 32853647 — Predictive Biomarker (PRD): FOXO3 mRNA
Genes: FOXO3; FKHRL1; FOXO3A
Study 32853647 — Predictive Biomarker (PRD): MEF2C mRNA
Genes: MEF2C
Study 32853647 — Predictive Biomarker (PRD): PPARGC1A mRNA
Genes: PPARGC1A; LEM6; PGC1; PGC1A; PPARGC1
Study 32853647 — Predictive Biomarker (PRD): Mothers against decapentaplegic homolog 2
Genes: SMAD2; MADH2; MADR2
Study 32853647 — Predictive Biomarker (PRD): SMAD3 mRNA
Genes: SMAD3; MADH3
Study 33560349 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study 33560349 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33479188 — Predictive Biomarker (PRD): EVL mRNA
Genes: EVL; RNB6
Study 36027441 — Surrogate Endpoint (SUR): Blood pressure
Study 36364734 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32735886 — Safety Biomarker (SAF): Reactive oxygen species
Study 32735886 — Surrogate Endpoint (SUR): Blood pressure
Study 35761105 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 35761105 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35761105 — Safety Biomarker (SAF): miR-146a
Genes: MIR146A
Study 34429614 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 34429614 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 33248986 — Surrogate Endpoint (SUR): Blood pressure
Study 33248986 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33034564 — Surrogate Endpoint (SUR): Blood pressure
Study 33034564 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35665288 — Surrogate Endpoint (SUR): Blood pressure
Study 32761487 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL1 mRNA
Genes: CXCL1; GRO; GRO1; GROA; MGSA; SCYB1
Study 34419082 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 34419082 — Safety Biomarker (SAF): Reactive oxygen species
Study 33502473 — Predictive Biomarker (PRD): SRI mRNA
Genes: SRI
Study 33502473 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 34802253 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33439309 — Surrogate Endpoint (SUR): Bone mineral density
Study 35045416 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 36147577 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 36147577 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35575053 — Predictive Biomarker (PRD): HHIP mRNA
Genes: HHIP; HIP; UNQ5825/PRO19644
Study 35575053 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study 33287713 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33287713 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34487346 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34487346 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 33888247 — Surrogate Endpoint (SUR): Blood pressure
Study 36227672 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36227672 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 36227672 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 34955301 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study 33039994 — Predictive Biomarker (PRD): PRKRA mRNA
Genes: PRKRA; PACT; RAX; HSD-14; HSD14
Study 33039994 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 33039994 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 35255916 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35255916 — Surrogate Endpoint (SUR): Blood pressure
Study 33872070 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32308204 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32308204 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 35485344 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35485344 — Monitoring Biomarker (MOI): HBV DNA
Study 36322562 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 36322562 — Surrogate Endpoint (SUR): Blood pressure
Study 35346577 — Monitoring Biomarker (MOI): HBV DNA
Study 35094079 — Surrogate Endpoint (SUR): Serum uric acid
Study 33472172 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 32148226 — Predictive Biomarker (PRD): PIP mRNA
Genes: PIP; GCDFP15; GPIP4
Study 32558951 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36448621 — Surrogate Endpoint (SUR): Blood pressure
Study 35218559 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 32951715 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32951715 — Surrogate Endpoint (SUR): Blood pressure
Study 35800160 — Surrogate Endpoint (SUR): Blood pressure
Study 36282537 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 35691250 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 35896277 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35896277 — Surrogate Endpoint (SUR): Serum potassium
Study 33233955 — Surrogate Endpoint (SUR): Blood pressure
Study 33174234 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33174234 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34823018 — Safety Biomarker (SAF): Reactive oxygen species
Study 32551796 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 33492394 — Surrogate Endpoint (SUR): Blood pressure
Study 32374844 — Predictive Biomarker (PRD): AGO2 mRNA
Genes: AGO2; EIF2C2
Study 32374844 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-122
Genes: MIR122
Study 32374844 — Predictive Biomarker (PRD): miR-17
Genes: MIR17
Study 33630870 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33630870 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 36043711 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32917151 — Surrogate Endpoint (SUR): Blood pressure
Study 32941649 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 34389292 — Surrogate Endpoint (SUR): Blood pressure
Study 33440088 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33440088 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33440088 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33931997 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35135549 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 36180035 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study 36180035 — Predictive Biomarker (PRD): PTBP2 mRNA
Genes: PTBP2; NPTB; PTB; PTBLP
Study 32647023 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 35436890 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 32821503 — Predictive Biomarker (PRD): ABCA4 mRNA
Genes: ABCA4; ABCR
Study 36280027 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36280027 — Surrogate Endpoint (SUR): Blood pressure
Study 35773147 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36140045 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36140045 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36140045 — Surrogate Endpoint (SUR): Probing pocket depth
Study 36140045 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36140045 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 32171511 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 32176193 — Surrogate Endpoint (SUR): Blood pressure
Study 32592897 — Predictive Biomarker (PRD): REG3A mRNA
Genes: REG3A; HIP; PAP; PAP1
Study 34935585 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36322838 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34010748 — Predictive Biomarker (PRD): S100A10 mRNA
Genes: S100A10; ANX2LG; CAL1L; CLP11
Study 32014119 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 36176739 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 36441137 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33666156 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33666156 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35797618 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study 36145214 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32276883 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35623880 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study 34774348 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 34228102 — Surrogate Endpoint (SUR): Bone mineral density
Study 32325491 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 32325491 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 32325491 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 32325491 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 32325491 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 34026336 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 34026336 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study 34026336 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 32015513 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 33783495 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35413022 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32033527 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study 33441831 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 36301169 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36301169 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study 34198131 — Predictive Biomarker (PRD): SIGLEC1 mRNA
Genes: SIGLEC1; SN
Study 616521239 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 616521239 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34352069 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 34352069 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 34758056 — Safety Biomarker (SAF): Hyaluronic acid
Study 34639438 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 32524654 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study 35779616 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35779616 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 34161745 — Surrogate Endpoint (SUR): Blood pressure
Study 34388414 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 32220359 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 32220359 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35653229 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 32799851 — Safety Biomarker (SAF): Hyaluronic acid
Study 33558662 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33398094 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 32342619 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32342619 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33431967 — Predictive Biomarker (PRD): GPR65 mRNA
Genes: GPR65; TDAG8
Study 33431967 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33431967 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33431967 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study 33504555 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33504555 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 34032040 — Surrogate Endpoint (SUR): Bone mineral density
Study 36341753 — Surrogate Endpoint (SUR): Blood pressure
Study 34108140 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study 35995953 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 35807783 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 35807783 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 35807783 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35400227 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 33302751 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33829609 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33829609 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33056965 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 33762716 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study 33762716 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36653090 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 36653090 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35799473 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 33728806 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33728806 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32538762 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32538762 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 34107173 — Predictive Biomarker (PRD): MOXD1 mRNA
Genes: MOXD1; MOX; UNQ2493/PRO5780
Study 34657222 — Surrogate Endpoint (SUR): Blood pressure
Study 35685430 — Predictive Biomarker (PRD): RRS1 mRNA
Genes: RRS1; KIAA0112; RRR
Study 33290938 — Predictive Biomarker (PRD): NR4A2 mRNA
Genes: NR4A2; NOT; NURR1; TINUR
Study 33290938 — Predictive Biomarker (PRD): AUTS2 mRNA
Genes: AUTS2; KIAA0442
Study 33290938 — Predictive Biomarker (PRD): TFAM mRNA
Genes: TFAM; TCF6; TCF6L2
Study 34139801 — Predictive Biomarker (PRD): FOXO3 mRNA
Genes: FOXO3; FKHRL1; FOXO3A
Study 33119068 — Predictive Biomarker (PRD): SPR mRNA
Genes: SPR
Study 32095935 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32095935 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32095935 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36278294 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 33368696 — Surrogate Endpoint (SUR): Serum creatinine
Study 32940642 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 32940642 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32286232 — Surrogate Endpoint (SUR): Blood pressure
Study 34619162 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36107424 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33081825 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36438274 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33846151 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study 36072909 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 33652910 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 33652910 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37409838 — Surrogate Endpoint (SUR): Blood pressure
Study 34376533 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34376533 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34376533 — Predictive Biomarker (PRD): Hormone receptor
Study 34833666 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 34833666 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 33495294 — Surrogate Endpoint (SUR): Blood pressure
Study 34284726 — Safety Biomarker (SAF): miR-206
Genes: MIR206
Study 34284726 — Safety Biomarker (SAF): miR-133
Study 34284726 — Surrogate Endpoint (SUR): Bone mineral density
Study 35609292 — Surrogate Endpoint (SUR): Blood pressure
Study 35451636 — Surrogate Endpoint (SUR): Blood pressure
Study 34579127 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 34495078 — Surrogate Endpoint (SUR): Blood pressure
Study 34340097 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study 35961468 — Predictive Biomarker (PRD): LTB4R mRNA
Genes: LTB4R; BLT; BLT1; BLTR; CMKRL1; GPR16; P2RY7
Study 34154363 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 34154363 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33068343 — Predictive Biomarker (PRD): MCAT mRNA
Genes: MCAT; MT
Study 36378691 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34326921 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 32415846 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32825982 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 35353055 — Surrogate Endpoint (SUR): Blood pressure
Study 35353055 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35353055 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33032908 — Surrogate Endpoint (SUR): Sperm parameters
Study 35998119 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 33219117 — Surrogate Endpoint (SUR): Blood pressure
Study 33219117 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33219117 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33298149 — Safety Biomarker (SAF): Interleukin 1
Study 33298149 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33749321 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 32291608 — Predictive Biomarker (PRD): BCL2A1 mRNA
Genes: BCL2A1; BCL2L5; BFL1; GRS; HBPA1
Study 32291608 — Predictive Biomarker (PRD): GCH1 mRNA
Genes: GCH1; DYT5; GCH
Study 32291608 — Safety Biomarker (SAF): Hypoxanthine-guanine phosphoribosyltransferase
Genes: HPRT1; HPRT